We are delighted to add our latest Educational Series titled: Maintenance therapy post-autologous stem cell transplantation for patients with newly diagnosed multiple myeloma. This review summarises the evidence, from randomised controlled trials and real-world studies, for the use of lenalidomide as continuous maintenance treatment.
The review includes guiding commentary from Dr Wojt Janowski, a clinical and laboratory haematologist at the Calvary Mater Newcastle, NSW Pathology, and Hunter Valley Haematology.
Please login below to download this issue (PDF)